3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
277
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Recurrence
43
Neoplasms, Plasma Cell
32
Leukemia
29
Lymphoma
25
Neoplasms
23
Vomiting
21
Burkitt Lymphoma
20
Lymphoma, Non-Hodgkin
19
Nausea
17
Immunoglobulin Light-chain Amyloidosis
17
Lymphoma, Mantle-Cell
16
Carcinoma, Non-Small-Cell Lung
15
Prostatic Neoplasms
14
Waldenstrom Macroglobulinemia
13
Lymphoma, Follicular
13
Breast Neoplasms
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large B-Cell, Diffuse
11
Leukemia, Myeloid, Acute
10
Lymphoma, B-Cell, Marginal Zone
9
Amyloidosis
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
8
Neoplasm Metastasis
7
Hematologic Neoplasms
7
Smoldering Multiple Myeloma
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Interventions
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
tocilizumab
1
sotrovimab
1
proxalutamide
1
bemcentinib
1
Therapeutics
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Sodium Chloride
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Janus Kinase Inhibitors
1
Influenza Vaccines
1
Hydroxychloroquine
1
HuMax-IL8
1
Gelsolin
1
Diagnostic Tests, Routine
1
Decision Support Techniques
1
COVID-19 Vaccines
1
Blood Specimen Collection
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
COVID-19
×
Dexamethasone
×
Clear all
No trials found.